NUTX Nutex Health, Inc.
Healthcare$123.20+3.61%ClosedMarket Cap: $733.6M
As of 2026-05-26
Valuation
P/E (TTM)
9.54
PEG
0.41
P/B
2.30
P/S
0.80
EV/EBITDA
2.91
DCF Value
$-507.15
FCF Yield
38.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
47.5%
Operating Margin
31.4%
Net Margin
11.0%
ROE
31.4%
ROA
10.1%
ROIC
26.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $216.5M | 42.4% | $81.3M | $46.8M | $— | — |
| Q4 null | $151.7M | 30.4% | $30.9M | $11.8M | $— | — |
| FY null | $875.3M | 50.8% | $275.6M | $70.8M | $— | — |
| Q3 null | $267.8M | 57.8% | $130.4M | $55.4M | $— | — |
| Q2 null | $244.0M | 51.2% | $33.7M | $-17.7M | $— | — |
| Q1 null | $211.8M | 55.9% | $72.2M | $14.6M | $— | — |
| Q4 null | $257.6M | 55.0% | $114.2M | $61.7M | $— | — |
| FY null | $479.9M | 40.9% | $130.6M | $52.2M | $— | — |
| Q3 null | $78.8M | 27.8% | $9.7M | $-8.8M | $— | — |
| Q2 null | $76.1M | 29.7% | $5.3M | $-364.0K | $— | — |
| Q1 null | $67.5M | 15.1% | $1.4M | $-364.1K | $— | — |
| Q4 2023 | $69.7M | 19.0% | $-26.1M | $-31.6M | $-7.50 | — |